Lisdexamfetamine, marketed as Vyvanse, is a prescription drug authorized in Canada for addressing Attention-Deficit/Hyperactivity Disorder (ADHD) in children and people. This functions as a prodrug, meaning https://lisdexamfetamineincanada428598.blogitright.com/43451067/vyvanse-in-the-nation-a-detailed-overview